ElectroCore has been granted a patent for a method to treat symptoms of PTSD by applying electrical impulses transcutaneously to the vagus nerve. The treatment involves specific parameters and protocols for effective symptom reduction. GlobalData’s report on ElectroCore gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights ElectroCore Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on ElectroCore, Cardiac stimulation implants was a key innovation area identified from patents. ElectroCore's grant share as of January 2024 was 65%. Grant share is based on the ratio of number of grants to total number of patents.

Treatment of ptsd using electrical impulses on vagus nerve

Source: United States Patent and Trademark Office (USPTO). Credit: ElectroCore Inc

A recently granted patent (Publication Number: US11865329B2) discloses a method for treating symptoms of post-traumatic stress disorder (PTSD) in patients. The method involves positioning a device's contact surface on the anterior portion of the patient's neck and applying an electrical impulse transcutaneously to the vagus nerve for 90 seconds to 3 minutes. This impulse, characterized by specific burst and constant periods, aims to modify the vagus nerve and reduce PTSD symptoms by alternating between positive and negative electric field charges.

The patented method includes using electrodes coupled to an energy source, attaching them to the patient's neck, and following a stimulation protocol involving multiple doses separated by specific time frames. The electrical impulse's frequency, burst period characteristics, and duration of pulses are crucial in causing the release of inhibitory neurotransmitters like GABA, serotonin, or norepinephrine in the patient's brain. The treatment paradigm can include multiple treatments per day, each comprising at least two doses administered within a short interval, with the overall protocol ranging from 2 to 12 treatments per day. This innovative approach offers a non-invasive and potentially effective way to alleviate PTSD symptoms by targeting the vagus nerve through transcutaneous electrical stimulation.

To know more about GlobalData’s detailed insights on ElectroCore, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.